Sana Biotechnology, Inc.
SANA
$3.55
-$0.12-3.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -63.64M | -47.21M | -58.83M | -42.15M | -93.80M |
| Total Depreciation and Amortization | 2.23M | 2.39M | 3.05M | 3.19M | 2.86M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.49M | 13.95M | 19.72M | 8.84M | 61.21M |
| Change in Net Operating Assets | 1.12M | -6.51M | 3.41M | 697.00K | -3.37M |
| Cash from Operations | -32.79M | -37.38M | -32.64M | -29.43M | -33.10M |
| Capital Expenditure | -1.62M | -288.00K | -873.00K | -41.00K | 112.00K |
| Sale of Property, Plant, and Equipment | 23.00K | 248.00K | 661.00K | 136.00K | 382.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -85.92M | 49.48M | -16.28M | -48.12M | 7.19M |
| Cash from Investing | -87.52M | 49.44M | -16.50M | -48.03M | 7.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -93.00K | -91.00K | -89.00K | -87.00K | -86.00K |
| Issuance of Common Stock | 93.58M | 59.00K | 17.74M | 109.63M | 587.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.00K | -96.00K | -- | -- | 60.00K |
| Cash from Financing | 93.58M | -128.00K | 17.65M | 109.54M | 561.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.73M | 11.93M | -31.49M | 32.09M | -24.86M |